HomeAI · summaries
Storia in 3 fonti
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA extends approval of Tivicay to treat newborns with HIV
The FDA has extended its approval of dolutegravir tablets for oral suspension to treat newborns with HIV. Dolutegravir tablets (Tivicay, ViiV Healthcare) and dolutegravir tablets…
- ·
medpagetoday.com
FDA Expands Label of Oral HIV Drug to Newborns
Dolutegravir is already approved as combination therapy in adults and older children
